trastuzumab biosimilar
/ PlantForm
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 26, 2017
Trastuzumab biosimilar: Launch in world markets in 2021
(PlantForm Corporation)
- Investor Presentation
Biosimilar launch • Biosimilar
August 22, 2013
PlantForm secures $2 million in equity financing
(Exchange Magazine)
- “PlantForm aims to launch its biosimilar trastuzumab, in partnership with a pharmaceutical company, in world markets, beginning in Europe in 2017.”
Anticipated biosimilar launch • Biosimilar
1 to 2
Of
2
Go to page
1